Literature DB >> 391261

The events leading to the death of patients with pemphigus and pemphigoid.

J A Savin.   

Abstract

This paper is based upon a study of all available records of patients certified as having died in hospital from pemphigus and pemphigoid in England and Wales from 1962 to 1969. The results differ from most published series in that many of the 210 patients died still with extensive skin lesions and with biochemical abnormalities, such as low serum albumin, sodium and chloride, which were secondary to this. Side-effects of treatment, such as diabetes, peptic ulceration, and infections, were also important but the commonest immediate causes of death were respiratory tract infections and pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391261     DOI: 10.1111/j.1365-2133.1979.tb11881.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Interventions for bullous pemphigoid.

Authors:  Gudula Kirtschig; Philippa Middleton; Cathy Bennett; Dedee F Murrell; Fenella Wojnarowska; Nonhlanhla P Khumalo
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

4.  Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature.

Authors:  Meital Oren-Shabtai; Noa Kremer; Moshe Lapidoth; Eran Sharon; Lihi Atzmony; Adi Nosrati; Emmilia Hodak; Daniel Mimouni; Assi Levi
Journal:  Drugs Aging       Date:  2020-11-24       Impact factor: 3.923

5.  Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

Authors:  J M Mason; J R Chalmers; T Godec; A J Nunn; G Kirtschig; F Wojnarowska; M Childs; D Whitham; E Schmidt; K Harman; S Walton; A Chapman; H C Williams
Journal:  Br J Dermatol       Date:  2018-01-15       Impact factor: 9.302

6.  Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.

Authors:  Hywel C Williams; Fenella Wojnarowska; Gudula Kirtschig; James Mason; Thomas R Godec; Enno Schmidt; Joanne R Chalmers; Margaret Childs; Shernaz Walton; Karen Harman; Anna Chapman; Diane Whitham; Andrew J Nunn
Journal:  Lancet       Date:  2017-03-06       Impact factor: 79.321

Review 7.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.